Cargando…
The Role of Co-Stimulatory Molecules in Chagas Disease
Chagas disease, caused by Trypanosoma cruzi, is a potentially life-threatening tropical disease endemic to Latin American countries that affects approximately 8 million people. In the chronic phase of the disease, individuals are classified as belonging to the indeterminate clinical form or to the c...
Autores principales: | Pinto, Bruna F., Medeiros, Nayara I., Fontes-Cal, Tereza C. M., Naziazeno, Isabela M., Correa-Oliveira, Rodrigo, Dutra, Walderez O., Gomes, Juliana A. S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6262639/ https://www.ncbi.nlm.nih.gov/pubmed/30405039 http://dx.doi.org/10.3390/cells7110200 |
Ejemplares similares
-
CD86 Expression by Monocytes Influences an Immunomodulatory Profile in Asymptomatic Patients with Chronic Chagas Disease
por: Pinto, Bruna F., et al.
Publicado: (2018) -
Modulation of Regulatory T Cells Activity by Distinct CD80 and CD86 Interactions With CD28/CTLA-4 in Chagas Cardiomyopathy
por: Pinto, Bruna F., et al.
Publicado: (2022) -
Evidence of Different IL-1β Activation Pathways in Innate Immune Cells From Indeterminate and Cardiac Patients With Chronic Chagas Disease
por: Medeiros, Nayara I., et al.
Publicado: (2019) -
Differential Expression of Matrix Metalloproteinases 2, 9 and Cytokines by Neutrophils and Monocytes in the Clinical Forms of Chagas Disease
por: Medeiros, Nayara I., et al.
Publicado: (2017) -
MMP-2 and MMP-9 plasma levels are potential biomarkers for indeterminate and cardiac clinical forms progression in chronic Chagas disease
por: Medeiros, Nayara I., et al.
Publicado: (2019)